Tuberculosis and Leprosy Flashcards

1
Q

What is M. bovis?

A
  • causes tuberculosis in cows, rarely in humans

- humans can be infected by the consumption of unpasteurized milk leading to extrapulmonary tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is M. avium?

A
  • can cause a tuberclosis-like illness in humans, particularly in AIDS patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is M. leprae?

A
  • the causative agent of leprosy in humans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Tuberculosis?

A
  • infection by M. tuberculosis
  • can be latent or active
  • many people have the latent form
  • contagious and spread through the air by people with active TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is M. turberculosis?

A
  • intracellular pathogen (lives within macrophages)
  • can be grown in the lab on specialized media but takes 4-6 weeks to get small colonies
  • slow generation time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mycobacteria structure

A
  • have an unusual cell envelop with high concentrations of mycolic acid which is ‘waxy’
  • the unusual cell envelope is associated with resistance to
  • many antibiotics
  • killing by acidic and alkaline compounds
  • osmotic lysis via complement deposition
  • lethal oxidative stress promoting survival inside of macrophages
  • impermeability to stains and dyes
  • gram-positive acid-fast stain
  • waxy lipid-rich cell envelope resists common strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are acid-fast stain

A
  • stained with carbol-fuchsin dye with slow heating (to melt wax)
  • washed with EtOH and HCl
  • counterstained with methylene blue
  • acid-fast organisms appear red whereas non-acid fast organisms appear blue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is stage 1 of the spread and progression of tuberculosis?

A
  • transmission is from inhalation of droplets from an infected host, usually by coughing or sneezing
  • coughing/sneezing can generate 3000 droplet nuclei
  • droplet nuclei can contain around 3 bacteria
  • small diameter droplets can stay airborne for extended periods of time
  • airborne droplets can be inhaled directly into the lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is stage 2 of the spread and progression of tuberculosis?

A
  • phagocytosis of TB cells by lung (alveolar) macrophages
  • TB blocks acidification of the phagosome
  • inhibits the fusion of the lysosome to the phagosome
  • multiplies in macrophages
  • macrophages lyse and release TB cells to infect more macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is stage 3 of the spread and progression of tuberculosis?

A
  • infected macrophages may form granulomas
  • TB granulomas are “tubercles” of immune cells that try to destroy invading pathogens (typically formed by macrophages)
  • granuloma represents a “balance” between the pathogen and the host -> latent infection
  • T cell activated macrophages can kill TB
  • activated T cells can secrete cytokines (IFN-gamma) to activate the macrophages
  • macrophages at the center of the granuloma remain harder to activate by T cells
  • chronic inflammation cause “cheese-like” necrosis
  • caseous necrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is stage 4 of the spread and progression of tuberculosis?

A
  • some macrophages remain unactivated and infected
  • tubercule grows
  • erosion of the granuloma into the airway provides the route of transmission
  • deterioration of host immunity can result in a life-threatening infection
  • active tuberculosis
  • the caseous center can liquefy leading to cavitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is extrapulmonary tuberculosis

A
  • infection outside the lungs
  • more likely to occur in immunocompromised (HIV-infected patients) individuals and young children
  • can infect bone, joints, liver, spleen, gastrointestinal tract and brain
  • widespread dissemination, called miliary tuberculosis is almost always fatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Testing and diagnosis

A
  • tuberculin test (PPD = purified protein derivative from M. tuberculosis)
  • based on T cell-mediated response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Positive tuberculin test

A
  • red and swollen circle at 48h
  • a person is considered infected if they convert from negative to positive on a TB skin test
  • latent or active TB
  • BCG vaccinated
  • previously infected
  • a careful history and a chest X-ray
  • X-ray: typical upper lobe “shadowing” -> lesions
  • calcified granulomas may be seen on an X-ray
  • staining of sputum for acid-fast bacilli and culturing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Negative tuberculin test

A
  • not infected
  • immune-compromised (AIDS)
  • not infected long enough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment

A
  • active TB will kill 2 out of 3 people if untreated
  • 6 months of antibiotics for the short treatment
  • slow growth means long treatments
  • generally, multiple types of antibiotics are used
17
Q

What are the multiple types of antibiotics are used?

A
  • Rifampin (inhibits RNA polymerase)
  • Isoniazid (inhibits mycolic acid synthesis)
  • others…
18
Q

Drug-resistant TB

A
  • multi-drug resistant TB (MDR-TB)
  • defined as being resistant to the two most effective first-line therapeutic drugs, isoniazid and rifampin
  • XDR-TB has been found in all regions of the world
  • these strains can be virtually untreatable
19
Q

Bacille Calmette-Guerin (BCG)

A
  • a living vaccine prepared from attenuated M. Bovis
  • shares antigenicity with TB
  • controversial due to variable efficacy (80% or much less) for pulmonary TB
  • effective against miliary TB
  • vaccinated individuals can give a false positive for the tuberculin test
  • vaccination leaves large scars
  • recommended for individuals with high risk to exposure
20
Q

What is leprosy

A
  • a chronic disease
  • also called Hansen’s disease
  • very slow progression
  • the incubation period of around 5 years
  • can cause permanent damage to skin, nerves, limbs and eyes
  • leprosy is rare in developed countries
  • shares some features with M. tuberculosis
  • many people are disabled by leprosy, mainly in tropical developing countries
  • Gram-positive, acid-fast, rod-shaped, waxy cell envelope (mycolic acid)
  • cannot be cultivated in vitro
  • can grow in footpads in armadillos
  • infects macrophages of skin and Schwann cells in nerves
21
Q

History and leprosy

A
  • victims have been ostracized
  • rejected by families and friends
  • driven from communities
  • killed
  • lesions in tuberculosis is “hidden”
  • lesions in leprosy are “visible”
  • but is much less infectious than TB
22
Q

What are the two forms of leprosy

A
  • tuberculoid

- lepromatous

23
Q

What is tuberculoid leprosy?

A
  • cell-mediated immunity present
  • macrophages can contain the bacteria
  • light coloured lesions with “anesthetic” areas
  • sometimes loss of hair and pigmentation
  • patients become tuberculin positive (active T cell-mediated responses)
  • bacterial cells are generally not recoverable from lesions
  • can be self-limiting
24
Q

What is lepromatous leprosy?

A
  • cell-mediated immune responses are absent
  • macrophages are not activated
  • M. leprae survives and multiplies in macrophages and Schwann cells
  • due to nerve damage and loss of sensation leads to inadvertent traumatic lesion on the face and extremities
  • can cause loss of eyebrows, thickening and enlarged noses, ears and cheeks
  • lion-like appearance
  • lesions can become secondarily infected, eventually resulting in bone resorption, disfigurements and mutilation
25
Q

Spread and progression of leprosy

A
  • transmission is not well understood
  • probably close (direct) contact for extended periods of time
  • inhaled droplets?
  • most exposed individuals do not develop the disease
  • host genetics likely plays an important role
26
Q

Treatment of leprosy

A
  • treatable with antibiotics
  • multiple drugs are used (6 months to a year)
  • clapsone - resistance developed in the 1960s
  • multidrug therapy (MDT) - dapsone, rifampin, clofazimine
  • patients no longer transmit the disease after one dose of MDT